Regis Technologies
Regis Custom Pharma offers a complete package for impurity isolation and characterization services (Structure Elucidation) to support IND and NDA filings.
Regis Custom Pharma offers a complete package for impurity isolation and characterization services (Structure Elucidation) to support IND and NDA filings. Regis is also a leading global supplier of chromatography products. Visit booth 1752 to learn more about their Custom Pharma services for small molecules, new achiral SFC columns, chiral columns for LC and SFC, and specialty columns and reagents.
Regis Technologies
8210 Austin Avenue
Morton Grove, IL US 60053
sales @registech.com
tel. 847.967.6000
fax. 857.967.5876
Pittcon Booth #: 1752
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
